It is well recognized that current batteries of genetic toxicology assays exhibit relatively high sensitivity, meaning they effectively identify genotoxic carcinogens. However, a critical deficiency with current approaches exists-namely, the specificity of the in vitro mammalian cell genotoxicity tests is low, as they yield a high incidenc of positive results that do not have in vivo relevance (so-called misleading or irrelevant positives). This high incidence of irrelevant in vitro positive results leads to extensive and costy additional testing, often with whole animal models, or else abandonment of potentially valuable products. We will address this major problem with current in vitro mammalian cell genetic toxicity assays by developing commercial kits that enable an automated testing strategy that exhibits both high sensitivity and specificity. This system will categorize positive results according to the predominant mode of genotoxic activity, and importantly, will reliably identify irrelevant mode(s) of action that are likely to be nonoperational in vivo. A secondary objective of the proposed work is the development of methods for characterizing clastogens. That is, we will develop tools that elucidate whether clastogenic activity is the result of DNA-reactivity, or whether it is mediated by an indirect mechanism.

Public Health Relevance

Sub-lethal DNA damage that cannot be faithfully repaired results in gene mutation and/or chromosomal aberrations, and these effects are known to contribute to carcinogenesis. There is also emerging evidence that DNA damage contributes to germline (genetic) disorders and other disease sequelae, for instance atherosclerosis. Thus, there is an important need for sensitive and specific assays to evaluate chemicals for genotoxic potential. Furthermore, in cases when genotoxic potential has been determined, more efficient means of elucidating genotoxic mode of action would be useful for understanding human health risks.

National Institute of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Shaughnessy, Daniel
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Litron Laboratories, Ltd.
United States
Zip Code
Smith-Roe, Stephanie L; Swartz, Carol D; Shepard, Kim G et al. (2018) Black cohosh extracts and powders induce micronuclei, a biomarker of genetic damage, in human cells. Environ Mol Mutagen 59:416-426
Bryce, Steven M; Bernacki, Derek T; Bemis, Jeffrey C et al. (2017) Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay. Environ Mol Mutagen 58:146-161
Bernacki, Derek T; Bryce, Steven M; Bemis, Jeffrey C et al. (2016) ?H2AX and p53 responses in TK6 cells discriminate promutagens and nongenotoxicants in the presence of rat liver S9. Environ Mol Mutagen 57:546-558
Bryce, Steven M; Bernacki, Derek T; Bemis, Jeffrey C et al. (2016) Genotoxic mode of action predictions from a multiplexed flow cytometric assay and a machine learning approach. Environ Mol Mutagen 57:171-89